MALAT1 and prostate cancer: Initial studies using MALAT1 siRNAs demonstrated inhibition of cell migration, growth, and invasion in prostate cancer cells [126], while siRNAs directed against HOTAIR have been shown to reduce matrix invasion in breast cancer cells [20].